Endurance Wealth Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-8,440
Closed -$838K 560
2019
Q3
$838K Sell
8,440
-350
-4% -$33.3K 0.14% 104
2019
Q2
$813K Sell
8,790
-150
-2% -$14.2K 0.13% 107
2019
Q1
$843K Sell
8,940
-6,975
-44% -$610K 0.14% 101
2018
Q4
$1.02M Sell
15,915
-2,430
-13% -$179K 0.19% 92
2018
Q3
$1.64M Hold
18,345
0.26% 81
2018
Q2
$1.46M Sell
18,345
-1,025
-5% -$85.1K 0.24% 83
2018
Q1
$1.73M Sell
19,370
-2,930
-13% -$281K 0.29% 79
2017
Q4
$2.33M Buy
22,300
+15,830
+245% +$1.79M 0.37% 63
2017
Q3
$943K Buy
+6,470
New +$881K 0.16% 97

Other funds holding CELG

Endurance Wealth Management's CELG Position: Q4 2019 in Review

Endurance Wealth Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 8,440 shares — an estimated $838K sold.

Endurance Wealth Management first reported a position in CELG in Q3 2017 and held it in 9 quarters. The position peaked at $2.33M in Q4 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Endurance Wealth Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Endurance Wealth Management sold 8,440 Celgene Corp shares in Q4 2019, an estimated $838K.
  • Endurance Wealth Management first reported a position in Celgene Corp in Q3 2017 and held it in 9 quarters.
  • Endurance Wealth Management's Celgene Corp position peaked at $2.33M in Q4 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Endurance Wealth Management's 13F filing for Q4 2019, filed 14 Jan 2020.